» Articles » PMID: 11069909

The Role of Disulfide Bridge in the Folding and Stability of the Recombinant Human Prion Protein

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Nov 9
PMID 11069909
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

It is believed that the critical step in the pathogenesis of transmissible spongiform encephalopathies is a transition of prion protein (PrP) from an alpha-helical conformation, PrP(C), to a beta-sheet-rich form, PrP(Sc). Native prion protein contains a single disulfide bond linking Cys residues at positions 179 and 214. To elucidate the role of this bridge in the stability and folding of the protein, we studied the reduced form of the recombinant human PrP as well as the variant of PrP in which cysteines were replaced with alanine residues. At neutral pH, the reduced prion protein and the Cys-free mutant were insoluble and formed amorphous aggregates. However, the proteins could be refolded in a monomeric form under the conditions of mildly acidic pH. Spectroscopic experiments indicate that the monomeric Cys-free and reduced PrP have molten globule-like properties, i.e. they are characterized by compromised tertiary interactions, an increased exposure of hydrophobic surfaces, lack of cooperative unfolding transition in urea, and partial loss of native (alpha-helical) secondary structure. In the presence of sodium chloride, these partially unfolded proteins undergo a transition to a beta-sheet-rich structure. However, this transition is invariably associated with protein oligomerization. The present data argue against the notion that reduced prion protein can exist in a stable monomeric form that is rich in beta-sheet structure.

Citing Articles

The cellular prion protein is a stress protein secreted by renal tubular cells and a urinary marker of kidney injury.

Bignon Y, Poindessous V, Lazareth H, Passet B, Vilotte J, Djouadi F Cell Death Dis. 2020; 11(4):243.

PMID: 32303684 PMC: 7165184. DOI: 10.1038/s41419-020-2430-3.


Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications.

Hackl S, Becker C J Pept Sci. 2019; 25(10):e3216.

PMID: 31713950 PMC: 6899880. DOI: 10.1002/psc.3216.


Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16.

Gobl C, Morris V, van Dam L, Visscher M, Polderman P, Hartlmuller C Redox Biol. 2019; 28:101316.

PMID: 31539802 PMC: 6812003. DOI: 10.1016/j.redox.2019.101316.


Novel prion mutation (p.Tyr225Cys) in a Korean patient with atypical Creutzfeldt-Jakob disease.

Bagyinszky E, Yang Y, Giau V, Youn Y, An S, Kim S Clin Interv Aging. 2019; 14:1387-1397.

PMID: 31447551 PMC: 6683949. DOI: 10.2147/CIA.S210909.


Microsecond sub-domain motions and the folding and misfolding of the mouse prion protein.

Goluguri R, Sen S, Udgaonkar J Elife. 2019; 8.

PMID: 31025940 PMC: 6516828. DOI: 10.7554/eLife.44766.